CA Stock MarketDetailed Quotes
MEND Nurosene Health Inc
- 0.000
- 0.0000.00%
15min DelayMarket Closed Jul 26 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.44552wk High0.00%Turnover Ratio47.35MShares0.30052wk Low-0.332EPS TTM0Float Cap3.170Historical High0.00P/E (Static)38.61MShs Float0.150Historical Low-0.332EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Nurosene Health Inc Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | (Q2)Mar 31, 2022 | (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | (Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -83.51%-4.78M | 38.81%-137.45K | 19.54%-772.54K | -38.25%-1.43M | -586.78%-2.44M | -1,631.42%-2.6M | -224.64K | -960.16K | -1.04M | -354.74K |
| Net income from continuing operations | -164.49%-13.45M | -166.12%-7.21M | 63.89%-857.39K | -244.01%-2.47M | -1,119.92%-2.9M | -1,638.45%-5.08M | ---2.71M | ---2.37M | ---719.1K | ---238.1K |
| Depreciation and amortization | --596.91K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Asset impairment expenditure | --5.76M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 3.10%1.25M | -76.82%184.67K | -176.88%-317.17K | 7,258.68%669.93K | 1,243.18%709.25K | 12,832.21%1.21M | --796.62K | --412.55K | --9.1K | --52.8K |
| Deferred tax | ---248.12K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non cashItems | -53.97%609.23K | -81.47%159.23K | -100.00%-1 | --1 | 3,114.29%450K | 1,040.03%1.32M | --859.41K | --464K | --0 | --14K |
| Change In working capital | 1,448.41%701.06K | -25.48%618.02K | -25.23%402.02K | 214.18%371.94K | -276.64%-690.92K | -412.34%-51.99K | --829.32K | --537.65K | ---325.76K | ---183.44K |
| -Change in receivables | 129.60%94.04K | 590.59%297.09K | 73.32%-68.6K | 14.59%-122K | 82.31%-12.45K | -959.70%-317.68K | ---60.56K | ---257.12K | ---142.84K | ---70.39K |
| -Change in inventory | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---61.8K | ---- | ---- |
| -Change in prepaid assets | 375.76%138.39K | 95.20%-5.72K | -26.52%50.73K | -53.66%55.15K | 146.26%38.23K | 47.92%-50.19K | ---119.23K | --69.04K | --119.01K | ---82.64K |
| -Change in payables and accrued expense | 41.07%445.6K | 169.26%326.65K | -72.78%214.37K | 159.27%468.79K | -259.94%-564.2K | 120.90%315.87K | ---471.66K | --787.53K | --180.81K | --352.77K |
| -Change in other working capital | --23.03K | --0 | --175.52K | --0 | 60.20%-152.49K | ---- | ---- | ---- | ---420.94K | ---383.19K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -83.51%-4.78M | 38.81%-137.45K | 19.54%-772.54K | -38.25%-1.43M | -586.78%-2.44M | -1,631.42%-2.6M | ---224.64K | ---960.16K | ---1.04M | ---354.74K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -34.96%-2.19M | 911 | 90.70%-131.9K | 0 | -2.06M | -1.62M | -1.42M | |||
| Net intangibles purchas and sale | 90.36%-152.49K | --0 | ---- | ---- | ---- | ---1.58M | ---- | ---1.42M | ---- | ---- |
| Net business purchase and sale | ---2.07M | ---13.49K | ---2 | --0 | ---2.06M | --0 | ---- | --0 | ---- | ---- |
| Net investment purchase and sale | 187.50%35K | --14.4K | ---- | ---- | ---- | ---40K | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -34.96%-2.19M | --911 | 90.70%-131.9K | --0 | ---2.06M | ---1.62M | ---- | ---1.42M | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -92.02%691.58K | -65.96%30.68K | -93.65%544.4K | 3K | -75.83%113.49K | 334.85%8.67M | 90.13K | 8.58M | 0 | 469.56K |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net common stock issuance | -93.37%575.09K | -122.10%-19.92K | -94.42%478.51K | --3K | -75.83%113.49K | 334.85%8.67M | --90.13K | --8.58M | --0 | --469.56K |
| Proceeds from stock option exercised by employees | --116.49K | ---1 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -92.02%691.58K | -65.96%30.68K | -93.65%544.4K | --3K | -75.83%113.49K | 334.85%8.67M | --90.13K | --8.58M | --0 | --469.56K |
| Net cash flow | ||||||||||
| Beginning cash position | 241.05%6.29M | -98.56%115.95K | -74.18%475.98K | -2.71%1.9M | 241.05%6.29M | --1.84M | --8.04M | --1.84M | --1.96M | --1.84M |
| Current changes in cash | -241.26%-6.28M | 93.97%-105.86K | -105.81%-360.03K | -37.96%-1.43M | -3,915.57%-4.38M | 141.05%4.44M | ---1.76M | --6.2M | ---1.04M | --114.83K |
| End cash Position | -99.84%10.09K | -99.84%10.09K | -98.56%115.95K | -48.39%475.98K | -2.71%1.9M | 241.05%6.29M | --6.29M | --8.04M | --922.26K | --1.96M |
| Free cash from | -17.79%-4.93M | 92.39%-137.45K | 61.12%-925.03K | -38.25%-1.43M | -586.78%-2.44M | -2,683.62%-4.19M | ---1.81M | ---2.38M | ---1.04M | ---354.74K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg